LEVITRA® 20mg Special Drug Use Investigation (Long-term)
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This investigation targets either the patients of 18 years-old or older and under 65
years-old with organic or mixed erectile dysfunction (ED) who cannot obtain sufficient
efficacy by dose 10mg of Levitra, and the target patients dose is increased to Levitra 20mg.
This investigation will be limited to the patients whose tolerability of Levitra 10mg is
judged to be no problem.